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Urticaria pigmentosa, one form of mastocy-
tosis, is usually manifested by the presence of
widely-distributed brownish macules which urti-
cate with mild trauma. Histologically the lesions
are characterized by a heavy mast cell infiltrate
of the dermis. Mast cells have been shown by
Riley (1) to contain large amounts of histamine.
Also, patients with urticaria pigmentosa have
been demonstrated (2) to excrete increased
quantities of histamine in the urine.
There are two possible explanations for this
abnormal histamine metabolism. The mast cells
of certain lower species have been shown to
contain an enzyme, histidine decarboxylase,
capable of synthesizing histamine so that the
large quantities of histamine excreted may
simply be due to overproduction. On the other
hand, large amounts of free histamine would
accumulate if one of the normal degradative
steps was either missing or greatly reduced. The
present study demonstrates a striking increase
in the histidine decarboxylase activity of skin
lesions of urticaria pigmentosa without any
dectectable effect on the histidine degradation.
METHODS
Histidine decarboxylase activity was deter-
mined by modification of methods earlier
described (3). In order to provide paired controls,
biopsies both of lesions and of uninvolved skin
were obtained from the six urticaria pigmentosa
patients previously reported (4). The subcuta-
neous layer was trimmed away and the remaining
tissue was weighed and stored frozen. Enough
tissue for analysis (125—250 mg.) was obtained
from each of the two adults; six biopsies of four
children were pooled, and yielded 160 mgs. of
involved skin and 130 mgs. of uninvolved skin. The
tissue was thawed, then using sterile technic,
minced with scissors, and an homogenate was
prepared using ice-cold Tyrode's solution. The
following additions were made: pyridoxal phos-
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phate (10 micrograms per milliliter), adenosine
triphosphate (1 milligram per milliliter), ferric
chloride (0.1 microgram per milliliter), and a
weighted amount (approximately 1 milligram) of
histidine-C'4 (12 microcuries per milligram; Nu-
clear Chemical Company). The mixture was
incubated anaerobically under sterile conditions
with shaking for three hours at 370 C. After addi-
tion of trichioroacetic acid (10 per cent) and
centrifugation, a clear supernatant fluid was
obtained.
Radioactive histamine formed during the incu-
bation was separated by paper and column
chromatography. For paper chromatography an
aliquot of the supernate was chromatographed on
Whitman 1 ifiter paper using n-butanol (5
parts) :10 per cent ammonium hydroxide (3 parts).
In this solvent system, histidine migrated slowly
(R, 0.05), while histamine travelled rather rapidly
(R 0.53). The area of the chromatograms corre-
sponding to that of histamine was eluted with HCI
(1 N). For column chromatography, another au-
quot of supernate was adsorbed on a Dowex 50
column, washed with phosphate buffer to remove
histidine (5) and histamine was eluted with HC1
(4 N). The eluates were then handled similarly;
carrier histamine dihydrochloride (25 mg.) was
added, the dipicrate was formed and recrystallized
several times. Following each recrystallization,
the yellow picric acid was removed with toluene
(5) and radioactivity was determined in a liquid
scintillation counter; recrystallization was re-
peated until constant specific activity was
achieved. These technics were demonstrated to
eliminate contamination by histidine when hista-
mine standards containing added radioactive
histidine were processed.
Urinary excretion of free histamine was esti-
mated by the method of Duner and Pernow (6).
Normal excretion by adult subjects ranged from 5
to 30 micrograms of free histamine in 24 hours.
A trace amount of radioactive histidine was
administered to two patients with urticaria pig-
mentosa, one patient with chronic urticaria, and
to eleven volunteer male control subjects. The
technics employed have been described (7) and
will be reviewed only briefly. All medications were
withheld for three weeks, and neither food nor
liquids were given for twelve hours immediately
prior to the experiment. Subjects received orally
10 microcuries of chromatographically pure,
uniformly labelled L-histidine-C'4 (approximately
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14 mg.) dissolved in orange juice. Urine was
collected for five hours, desalted, filtered, and
fractionated using two-step ion exchange column
chromatographic procedures in order to separate
the histidine metabolites. The following rue-
tabolites were separated and their amounts
measured (correct names in parentheses): hista-
mine; 1 ,4-methylhistamine, (1-methyl-4- (i3-ami-
noethyl) imidazole); 1 ,4-methylimidazole acetic
acid (1-methylimidazole-4-acetic acid); imidazole-
acetic acid (imidazole-4(5) acetic acid); ribosyl
imidazoleacetic acid, (1 -ribosylimidazole-4-acetic
acid); urocanic acid; formimino-glutamic acid;
glutamic acid; hydantoin proprionic acid; uric acid
and unknowns. Repeated recrystallizations and
isotope dilution determinations allowed final
quantitative analysis of radioactive metabolites.
Of the radioactivity initially administered orally,
about three per cent was present in the urine; of
this approximately one-third was histidine, ap-
parently excreted unchanged, and one-half was
present as unidentified metabolites.
CASE REPORTS
Case 1. Urticaria pigmentosa—The patient,
a 27-year-old caucasian female, reported in detail
previously (4), five years ago developed genera-
lized brownish maeules which urticated with mild
trauma. Skin biopsy was diagnostic. Headache,
flushing, gastrointestinal symptoms, oliguria and
weight loss have been associated with the erup-
tion. No laboratory or other evidence of systemic
lesions was found.
Case 2.' Urticaria pigmentosa (Adult type)—
The patient, a 32-year-old caucasian male was
presented at the Atlantic Dermatologic Confer-
ence, 1959, by Beerman and Hambrick (8). A
macular hyperpigmented eruption associated
with numerous telangiectatie vessels had devel-
oped one year earlier. Mild trauma of the lesions
caused pruritus. Skin biopsy was diagnostic.
Case 3. Chronic urticaria—The patient, a 24-
year-old caucasian male, noted the onset of
giant urticaria six months prior to study. Pruritic
cutaneous wheals involving primarily the thighs
and trunk appeared almost daily and generally
disappeared within six hours. With the exception
of occasional involvement of the lips, the patient
experienced no other symptoms. There was no
family history of urticaria, atopy or allergy.
Physical and laboratory findings were within
normal limits except for occasional transient
* Studied through the courtesy of Dr. George
Hambrick, University of Pennsylvania, Philadel-
phia, Pennsylvania.
eosinophilia (2—3 per cent). Despite intensive
study, the etiology of this urticaria could not
be determined.
RESULTS
Significant amounts of radioactive histamine
were formed by homogenates prepared from the
skin lesions of urtiearia pigmentosa (Table 1).
Radioactive histamine was recovered with both
chromatographic technics employed; column
chromatography yielded greater amounts. In
Table I are also shown the small amounts (con-
stant specific activity less than 2—3 times back-
ground) of radioactive histamine formed during
incubation of histidine with uninvolved skin.
TABLE 1
Rate of histamine formation by 8km homogenates of
urticaria pigmentosa
Histamine Formed (micro-
grams/gm. skin/3 hours)
Lesion tJninvolved
Case 1
(27-year-old female)
Case 4*
(51-year-old male)
Pooled Biopsies of Four
Children
205
180
110
15
30
10
* Reported in detail elsewhere (4).
TABLE II
a e
Free His La-
mine (mi-
crogram/
24 hours)
Case 1
Urticaria pig-
mentosa
Case 2
Urticaria pig-
mentosa
Case 3
Chronic urticaria
May 24, 1959
May 25, 1959*
May 31, 1959
June 1, 1959*
June 14, 1959
June 15, 1959*
260
120**
100
130**
60
70**
* Radioactive histidine administered these
dates.
** Total urinary free histamine estimated on
basis of five hour excretion. Urinary excretion of
free histamine by normal adult subjects ranged
from 5 to 30 micrograms in 24 hours.
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Heating the homogenates to boiling prior to
histidine incubation prevented the formation
of histamine, indicating this to be an enzymatic
process.
The enzymatic ability of homogenates of the
lesion to synthesize histamine is approximately
ten times that of uninvolved skin. The most
active preparation formed 0.68 micromoles of
histamine per gram of involved skin per hour.
Smaller amounts of histamine were formed by
the pooled biopsies from children (Table I) and
this may reflect less histidine decarboxylase
activity in childhood mastocytosis.
Table II records the urinary excretion of free
histamine by two patients with urticaria pig-
mentosa and one patient with chronic urticaria.
Tracer doses of radioactive histidine were ad-
ministered on the dates indicated and the urine
subsequently fractionated as described. There
were no significant diflerences between eleven
controls and the patients studied. The detailed
fractionation procedure did not reveal the pres-
ence of any peaks of radioactivity not found in
controls, nor were any of the normal metabolites
absent in urticaria pigmentosa or chronic
urticaria. It is especially noteworthy that despite
the increased urinary excretion of free histamine
by these patients, there was found, as with
controls, essentially no radioactivity in histamine
or any of its known metabolites.
DISCUSSION
Histidine decarboxylase has been demon-
strated in the peritoneal mast cells of the rat
(9) and in dog (10) and mouse (11) mastocy-
tomas. In certain of these species the mast cells,
unlike human mast cells (12), contain large
quantities of serotonin as well as histamine. It
was therefore of interest to determine if human
mast cells contained histidine decarboxylase.
In the present study, the formation of significant
quantities of histamine by homogenates of in-
volved skin of urticaria pigmentosa has been
demonstrated. Uninvolved skin, which in this
disease has been reported to contain slightly
greater than normal numbers of mast cells (13),
formed very small amounts of histamine. These
results implicate the mast cells as the site of
any enzyme (histidine decarboxylase) capable
of removing the terminal carboxyl group of
histidine (Fig. 1) to produce histamine.
Sporadic histamine release by the larger num-
bers of mast cells characteristic of mastocytosis
(urticaria pigmentosa) is presumably the source
of the markedly increased urinary excretion of
free histamine (2, 4). Some patients with chronic
HCC—CH2—CH —NH2 HISTIDINE
tIN I COOH
H
HC =C—CH2—CH2 —NH2
I I
HN N
"C,
I-IC =C—CH2 COOH
I I
tIN N
I 1
I
IMIDAZOLEACETIC
ACID
RISOSYL MID—
AZOLEACETIC
ACID
HC C— CH2 —C112 —NH2
CH3—N N
H
HISTAMINE
1,4 METHYLHISTAMINE
1,4 METHYLIMIDAZOLE
ACETIC ACID
HC =C—CH2 COOH
'I/\ /
RIBOSE C
H
HC C—CH2—COOH
N
CH3 C
H
FIG. 1. The Histamine Pathway of Histidine Metabolism. The known specific metabolites of hista-.
mine are 1 ,4-methylhistamine and 1,4-methylimidazole acetic acid. Imidazole acetic acid and ribosyl
imidazoleacetic acid can also be derived from histidine by a route not involving histamine.
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urticaria have also been reported to excrete
greater than normal amounts of histamine (14)
as did our patient (Case 3). While this histamine
is also presumably derived from mast cells, the
circumstances of its production are unclear; in-
creased numbers of mast cells are not known to
be characteristic of chronic urticaria.
Increased histamine excretion in both urticaria
pigmetosa and chronic urticaria prompted an
evaluation of histidine metabolism. The amino
acid histidine is converted via urocanic acid to
glutamic acid and a 1-carbon (formimino) moiety;
these compounds are subsequently involved in
many metabolic processes. Histidine is, in addi-
tion, directly methylated and involved in other
metabolic conversions. The histamine pathway
(Fig. 1) accounts for only a fraction of
metabolized histidine. These considerations ne-
cessitated collection of urine for only a relatively
short period (5 hours) in order to minimize
dilution by non-radioactive compounds. The
small dose of radioactive histidine employed
and the extensive metabolism of this amino acid
made longer periods of urine collection technically
infeasible.
The fate of histamine formed in vivo from the
decarboxylation of radioactive histidine in rats
has been shown by Schayer (15) to be strikingly
different from that of injected histamine-C14.
The latter is rapidly metabolized and virtually
all the radioactivity is excreted in the urine
within 24 hours. In contrast, histamine formed
in vivo is bound by mast cells and other cells
capable of storing histamine, and is liberated for
metabolism only slowly over a period of days.
It is therefore not surprising that the in vivo
studies reported here did not demonstrate radio-
activity in histamine or its metabolites in the
urine following histidine-C'4 administration.
These results imply that the increased amounts
of histamine formed by patients with urticaria
pigmentosa are also initially bound and not
immediately available for enzymatic breakdown.
While it is evident that a large metabolic pool
of histamine exists in patients with urticaria
pigmentosa (4) no estimate of its size can be
made at the present time. Studies presently
under way with parenteral administration of
radioactive histidine and histamine may allow
quantitation of this metabolic pooi.
SIThIMARY AND CONCLUSIONS
Histidine metabolism in patients with
urticaria pigmentosa has been investigated using
in vitro and in vivo technics, The skin lesions of
these patients were shown to have approximately
ten times as much histidine decarboxylase
activity as uninvolved skin. The metabolism of
orally administered histidine-C14 has been evalu-
ated in eleven controls, two patients with
urticaria pigmentosa, and one with chronic
urticaria. Despite increased urinary excretion
of free histamine by these patients, essentially
no radioactivity could be demonstrated within
the first five hours after administration in
histamine or its metabolites. The significance
of these results is discussed.
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DISCUSSION
Dn. ALLAN L. LORINCZ (Chicago, Ill.): I would
like to congratulate the presenters for this fine
study. Several months ago I also became in-
terested in the question of the origin of histamine
in mast cells, wondering whether these cells
actively made histamine from histidine or
whether they simply bound and stored histamine
brought to them by the circulation after absorp-
tion from the intestinal tract where this sub-
stance can be produced by bacterial action. To
obtain evidence pertaining to this question,
Dr. Yelva Lynfleld and I had the opportunity
to study a child with urticaria pigmentosa in the
Dermatology Clinic at the University of Chicago.
We greatly reduced the microbial flora of the
gut in this child with antibiotics to see whether
this would either diminish the urtication of the
lesions or extend the refractory period following
urtication. Neither of these factors were altered
by the antibiotic-induced, so-called gut steriliza-
tion. We concluded that histamine in mast cells
does not originate in a major way from bacterial
action on histidine in the intestinal tract. Our
clinical observation agrees very well with the
experimental demonstration of endogenous his-
tamine formation in mast cells we just have
heard so nicely presented.
Dn. GEED K. STEIGLEDEE (New York, N. Y.):
I have one question. Did you compare your
findings in urticaria pigmentosa with findings
in histiocytomas, or in other words, are common
human histiocytes able to form histamine?
Dn. STEPHEN Ro'rimw (Chicago, Ill.): The
finding of histidine decarboxylase in lesions of
urticaria pigmentosa is indeed significant. In
normal skin this enzyme was supposed to occur
and for a while it was thought that banal derma-
titides such as sunburn reaction are due to
decarboxylation of histidine to histamine.
However, no valid evidence was presented for
this view. The first step in the regular metabolism
of histidine in tissues is not decarboxylation but
deamination. In the skin the presence of the
deamination product, urocanic acid has been
demonstrated by Spier. However, in mast cells
the process may be different. I wonder if it was
shown that the decarboxylase is contained in
the granules rather than in the cytoplasm. Con-
cerning the experiments with feeding of histidine,
I wonder if the increase in histamine excretion
in the urine was significant. I would guess that
very little, if any, of the alimentary histidine is
decarboxylated to form histamine.
Dn. D. JOSEPH DEMIS (in closing): I wish to
thank all the discussors for their comments.
We are interested to hear of Dr. Lorincz's
observations. In this regard, I am not aware of
any evidence that mast cells can assimilate
histamine directly; data on this point is presently
lacking.
In answer to Dr. Maguire's question, we have
not studied the effect of stroking, trauma, or any
form of histamine release on the activity of this
enzyme. Histidine is decarboxylated rather
slowly. For example, when contrasted with dopa
decarboxylase, histidine decarboxylase is perhaps
'Iooo as active and consequently small changes
would have to be measured. Similarly, in answer
to Dr. Steigleder, we have not studied histio-
cytomas or other tissues to date.
In relation to Dr. Rothberg's query, the
concentration of pyridoxal 5'-phosphate em-
ployed was kept constant.
To answer Dr. Rothman's question, we hope
to study intracellular localization of histidine
decarboxylase in the human mast cells of urti-
caria pigmentosa. This enzyme has been localized
in the cytoplasm of mast cells of other species
and it will be of interest to determine whether
it has an intracytoplasmic location in human
mast cells as well.
